Pyrogens are fever causing substances after administering into the blood. The body ache and rise in body temperature are the notable reactions caused due to injection of unsafe pyrogens in the body. Monocyte activation testing determines the existence of pyrogen and endotoxin substances. The demand for pyrogen testing is currently not limited to the pharmaceutical companies and biological companies but is expanding among other end users too. The global monocyte activation tests market was valued approximately US$ 5.0 Mn in 2016 and is anticipated to register CAGR of over 14.0% from 2017 to 2025 to reach value of approximately US$ 19.0 Mn by 2025.

The global monocyte activation tests market is witnessing continuous innovations in test offerings and wide product portfolio of major as well as local manufacturers. The growth of the global monocyte activation tests market is mostly driven by increasing number of biotechnology and pharmaceutical companies globally, growing research and development investments and increasing new drug approvals. Moreover, additional aspects such as increasing healthcare expenditure, Increase in new innovative drugs and launch of biological products, increase in public and regulatory concerns about product safety support the market growth. Additionally, a proposed ban on animal tests reducing the use of the rabbit pyrogen test is one of the key factors that driving the growth of monocyte activation tests. Increasing contract research organization in the Latin American and Asia Pacific regions coupled with developing healthcare industry in emerging economies define the future landscape of the monocyte activation tests market.

monocyte-activation-test-market.jpg

The global monocyte activation tests market has been categorized on the basis of product type, source, application, end users, and geography. Among product types, the reagent segment accounted for the largest market share in 2016. However, monocyte activation test kits segment is anticipated to grow at a higher growth rate during the forecast period. Continuously rising adoption of superior-quality products newly introduced in the market are expected to drive the MAT kits segment during the forecast period. Among the sources, blood based segment accounted for the largest market share in 2016, blood-based MAT exhibits a natural human reaction to pyrogens and provides a better estimate of pyrogenic activity of preparations than the limulus amebocyte lysate (LAL) or rabbit pyrogen test (RPT). In term of application, medical devices segment accounted the largest market share in 2016. Increasing number of medical devices in market demands for the pyrogen test before approval in the market, this drives the medical devices segment. In end user segment pharmaceutical industry segment accounted for the major share in 2016, while biotechnology industry is anticipated to grow at higher CAGR during the forecast period, owing to factors such as increase in number of research studies in biotech companies to launch various new products likely to increase use of monocyte activation tests kits and reagents.

The global monocyte activation tests market has been divided into five main regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In terms of revenue, North America is projected to be the dominant market for global monocyte activation tests market in 2016 with more than 30.0% market share owing to many of the leading players located in the region coupled with expanding research and development activities and rising health care awareness. The North America monocyte activation tests market is likely to expand at an average CAGR during the forecast period. Reagent product type segment is estimated to hold the highest share of the North America monocyte activation tests market in 2016. Asia Pacific is expected to be the rapidly developing markets in terms of CAGR during the forecast period. The monocyte activation tests market in Europe is witnessing significant growth, increasing research activities in drug discovery and growing awareness about animal-free endotoxin detection are the key factors supporting the growth of the monocyte activation tests market in Europe. Rapidly growing medical devices, pharmaceutical, and biotechnology industry are primarily driving the growth of the global monocyte activation tests market. In addition, increasing government support and thereby increasing launch of new drugs is fueling the growth of the global monocyte activation tests market.

Key companies operating in the global monocyte activation tests market and profiled in the report include Merck KGaA, Thermo Fisher Scientific, Charles River Laboratories International, Inc., Sanquin, Microcoat Biotechnologie GmbH, Becton, Dickinson and Company, SOLVIAS AG and Lonza Group.

Global Monocyte Activation Tests Market: Overview

This report on monocyte activation tests studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various monocyte activation test products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global monocyte activation tests market with respect to the leading market segments based on major products, major source, significant applications, key end-users, and geographies.

The monocyte activation tests market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, source, application, end-user, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global monocyte activation tests market.

Global Monocyte Activation Tests Market: Key Segments

Based on product, the market has been segmented into monocyte activation test kits and reagents. Rising preference for animal-free detection of pyrogens has increased the demand for monocyte activation tests kits and reagents. The market size and forecast for each of these sub-segment have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on source, the market has been segmented into blood based, peripheral blood mononuclear cell (PBMC) based and cell line based. Factors such as lack of animal usage, reliability, and accuracy are expected to support the growth of the blood-based segment during the forecast period. The market size and forecast for each of these sub-segment have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year

Based on application, the market has been segmented into lipid parenteral, dialysis liquids, toxic/immune-modulatory drugs, blood products and medical devices. Various medical devices are launched in the market every year and before the launch, every device needs to undergo pyrogen testing. This factor is responsible for the continuing dominance of the sub-segment. The market size and forecast for each of these sub-segment have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on end-user, the market has been classified into pharmaceuticals industry, biotechnology industry, medical devices industry and others. Discovery and launch of new products fuel the growth of the pharmaceuticals and biotechnology industry segments, which in turn is projected to boost the growth of the monocyte activation tests market during the forecast period. The market size and forecast for each of these sub-segment have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Monocyte Activation Tests Market: Regional Outlook

Geographically, the global monocyte activation tests market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific  (India, China, Japan, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, Israel and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global monocyte activation tests market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players in this market are – Merck KGaA, Thermo Fisher Scientific, Charles River Laboratories International, Inc., Sanquin, Microcoat Biotechnologie GmbH, Becton, Dickinson and Company, SOLVIAS AG, and Lonza Group.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global monocyte activation tests market is segmented as given below:

Product

  • Monocyte Activation Test Kits
  • Reagents

Source

  • Blood Based
  • Peripheral Blood Mononuclear Bell (PBMC) Based
  • Cell line Based

Application

  • Lipid Parenteral
  • Dialysis Liquids
  • Toxic/immune-modulatory Drugs
  • Blood Products
  • Medical Devices

End-user

  • Pharmaceuticals Industry
  • Biotechnology Industry
  • Medical Devices Industry
  • Others

Revenue

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific (Except Japan)
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface 
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Monocyte Activation Test Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview 
     4.3. Market Dynamics
            4.3.1. Drivers 
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Monocyte Activation Test Market Analysis and Forecasts, 2015–2025
     4.5. Porter's Five Forces Analysis
     4.6. Advancement in Pyrogen Tests
     4.7. Healthcare Industry Overview
     4.8. Global Monocyte Activation Test (MAT): Turnaround Time

5. Global Monocyte Activation Test Market Analysis and Forecasts, By Product
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Market Value Forecast By Product, 2015–2025 
            5.3.1. Monocyte Activation Test Kits
            5.3.2. Reagents
     5.4. Market Attractiveness By Product

6. Global Monocyte Activation Test Market Analysis and Forecasts, By Source
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast By Source, 2015–2025
            6.3.1. Blood Based
            6.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            6.3.3. Cell Line Based
     6.4. Market Attractiveness By Source

7. Global Monocyte Activation Test Market Analysis and Forecasts, By Application
     7.1. Introduction and Definition
     7.2. Key Findings / Developments
     7.3. Market Value Forecast By Application, 2015–2025
            7.3.1. Lipid Parenteral
            7.3.2. Dialysis Liquids
            7.3.3. Toxic/immune-modulatory Drugs
            7.3.4. Blood Products
            7.3.5. Medical Devices
     7.4. Market Attractiveness By Application

8. Global Monocyte Activation Test Market Analysis and Forecasts, By End-user
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Market Value Forecast By End-user, 2015–2025
            8.3.1. Pharmaceuticals Industry
            8.3.2. Biotechnology Industry
            8.3.3. Medical devices Industry
            8.3.4. Others
     8.4. Market Attractiveness By End-user

9. Global Monocyte Activation Test Market Analysis and Forecasts, By Region 
     9.1. Key Findings
     9.2. Market Value Share Analysis and Forecast (2015-2025), By Region
            9.2.1. North America
            9.2.2. Europe
            9.2.3. Asia Pacific
            9.2.4. Latin America
            9.2.5. Middle East & Africa
     9.3. Market Attractiveness by Region

10. North America Monocyte Activation Test Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Forecast By Product, 2015–2025
            10.2.1. Monocyte Activation Test Kits
            10.2.2. Reagents
     10.3. Market Forecast By Source, 2015–2025
            10.3.1. Blood Based
            10.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            10.3.3. Cell Line Based
     10.4. Market Forecast By Application, 2015–2025
            10.4.1. Lipid Parenteral
            10.4.2. Dialysis Liquids
            10.4.3. Toxic/immune-modulatory Drugs
            10.4.4. Blood Products
            10.4.5. Medical Devices
     10.5. Market Forecast By End-users, 2015–2025
            10.5.1. Pharmaceuticals industry
            10.5.2. Biotechnology industry
            10.5.3. Medical devices industry
            10.5.4. Others
     10.6. Market Forecast By Country, 2015–2025
            10.6.1. U.S.
            10.6.2. Canada
     10.7. Market Attractiveness Analysis 
            10.7.1. By Product
            10.7.2. By Source
            10.7.3. By Application
            10.7.4. By End-user
            10.7.5. By Country

11. Europe Monocyte Activation Test Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Market Forecast By Product, 2015–2025
            11.2.1. Monocyte Activation Test Kits
            11.2.2. Reagents
     11.3. Market Forecast By Source, 2015–2025
            11.3.1. Blood Based
            11.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            11.3.3. Cell Line Based
     11.4. Market Forecast By Application, 2015–2025
            11.4.1. Lipid parenteral
            11.4.2. Dialysis liquids
            11.4.3. Toxic/immune-modulatory drugs
            11.4.4. Blood products
            11.4.5. Medical devices
     11.5. Market Forecast By End-users, 2015–2025
            11.5.1. Pharmaceuticals industry
            11.5.2. Biotechnology industry
            11.5.3. Medical devices industry
            11.5.4. Others
     11.6. Market Forecast By Country, 2015–2025
            11.6.1. Germany
            11.6.2. France
            11.6.3. U.K.
            11.6.4. Spain
            11.6.5. Italy
            11.6.6. Rest of Europe
     11.7. Market Attractiveness Analysis 
            11.7.1. By Product
            11.7.2. By Source
            11.7.3. By Application
            11.7.4. By End-user
            11.7.5. By Country

12. Asia Pacific Monocyte Activation Test Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Market Forecast By Product, 2015–2025
            12.2.1. Monocyte Activation Test Kits
            12.2.2. Reagents
     12.3. Market Forecast By Source, 2015–2025
            12.3.1. Blood Based
            12.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            12.3.3. Cell Line Based
     12.4. Market Forecast By Application, 2015–2025
            12.4.1. Lipid parenteral
            12.4.2. Dialysis liquids
            12.4.3. Toxic/immune-modulatory drugs
            12.4.4. Blood products
            12.4.5. Medical devices
     12.5. Market Forecast By End-users, 2015–2025
            12.5.1. Pharmaceuticals industry
            12.5.2. Biotechnology industry
            12.5.3. Medical devices industry
            12.5.4. Others
     12.6. Market Forecast By Country, 2015–2025
            12.6.1. China
            12.6.2. Japan
            12.6.3. India
            12.6.4. Australia & New Zealand
            12.6.5. Rest of Asia Pacific 
     12.7. Market Attractiveness Analysis 
            12.7.1. By Product 
            12.7.2. By Source
            12.7.3. By Application
            12.7.4. By End-user
            12.7.5. By Country

13. Latin America Monocyte Activation Test Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Market Forecast By Product, 2015–2025
            13.2.1. Monocyte Activation Test Kits
            13.2.2. Reagents
     13.3. Market Forecast By Source, 2015–2025
            13.3.1. Blood Based
            13.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            13.3.3. Cell Line Based
     13.4. Market Forecast By Application, 2015–2025
            13.4.1. Lipid parenteral
            13.4.2. Dialysis liquids
            13.4.3. Toxic/immune-modulatory drugs
            13.4.4. Blood products
            13.4.5. Medical devices
     13.5. Market Forecast By End-users, 2015–2025
            13.5.1. Pharmaceuticals industry
            13.5.2. Biotechnology industry
            13.5.3. Medical devices industry
            13.5.4. Others
     13.6. Market Forecast By Country, 2015–2025
            13.6.1. Brazil
            13.6.2. Mexico
            13.6.3. Rest of Latin America
     13.7. Market Attractiveness Analysis 
            13.7.1. By Product
            13.7.2. By Source
            13.7.3. By Application
            13.7.4. By End-user
            13.7.5. By Country

14. Middle East & Africa Monocyte Activation Test Market Analysis and Forecast
     14.1. Introduction
            14.1.1. Key Findings
     14.2. Market Forecast By Product, 2015–2025
            14.2.1. Monocyte Activation Test Kits
            14.2.2. Reagents
     14.3. Market Forecast By Source, 2015–2025
            14.3.1. Blood Based
            14.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
            14.3.3. Cell Line Based
     14.4. Market Forecast By Application, 2015–2025
            14.4.1. Lipid parenteral
            14.4.2. Dialysis liquids
            14.4.3. Toxic/immune-modulatory drugs
            14.4.4. Blood products
            14.4.5. Medical devices
     14.5. Market Forecast By End-users, 2015–2025
            14.5.1. Pharmaceuticals industry
            14.5.2. Biotechnology industry
            14.5.3. Medical devices industry
            14.5.4. Others
     14.6. Market Forecast By Country, 2015–2025
            14.6.1. South Africa
            14.6.2. Israel
            14.6.3. GCC
            14.6.4. Rest of Middle East & Africa
     14.7. Market Attractiveness Analysis 
            14.7.1. By Product
            14.7.2. By Source
            14.7.3. By Application
            14.7.4. By End-user
            14.7.5. By Country

15. Competition Landscape
     15.1. Key Players & Their Competitive Positioning (2016)
     15.2. Market Player – Competition Matrix (By Tier and Size of companies)
     15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy) 
            15.3.1. Merck KGaA
                      15.3.1.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.1.2. Financials
                      15.3.1.3. Recent Developments
                      15.3.1.4. SWOT Analysis
                      15.3.1.5. Strategy
            15.3.2. Thermo Fisher Scientific
                      15.3.2.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.2.2. Financials
                      15.3.2.3. Recent Developments
                      15.3.2.4. SWOT Analysis
                      15.3.2.5. Strategy
            15.3.3. Charles River Laboratories International, Inc.
                      15.3.3.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.3.2. Financials
                      15.3.3.3. Recent Developments
                      15.3.3.4. SWOT Analysis
                      15.3.3.5. Strategy
            15.3.4. Sanquin
                      15.3.4.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.4.2. Financials
                      15.3.4.3. Recent Developments
                      15.3.4.4. SWOT Analysis
                      15.3.4.5. Strategy
            15.3.5. Microcoat Biotechnologie GmbH
                      15.3.5.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.5.2. Recent Developments
                      15.3.5.3. SWOT Analysis
                      15.3.5.4. Strategy
            15.3.6. Becton, Dickinson and Company
                      15.3.6.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.6.2. Financials
                      15.3.6.3. Recent Developments
                      15.3.6.4. SWOT Analysis
                      15.3.6.5. Strategy
            15.3.7. SOLVIAS AG
                      15.3.7.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.7.2. Financials
                      15.3.7.3. Recent Developments
                      15.3.7.4. SWOT Analysis
                      15.3.7.5. Strategy
            15.3.8. Lonza Group
                      15.3.8.1. Overview (HQ, Employee Strength, Business Segments)
                      15.3.8.2. Financials
                      15.3.8.3. Recent Developments
                      15.3.8.4. SWOT Analysis
                      15.3.8.5. Strategy

List of Tables

Table 01: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 02: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 03: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 04: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 05: Global Monocyte Activation Tests Market Size (US$ Thousand) Forecast, by Region, 2015–2025
Table 06: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country, 2015–2025
Table 07: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 08: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 09: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 10: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 11: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 12: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 13: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 14: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 15: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 16: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 17: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 18: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 19: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 20: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 21: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 22: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 23: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 24: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 25: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 26: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 27: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 28: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 29: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 30: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025

List of Figures

Figure 01. Global Monocyte Activation Tests Market Size (US$ Thousand) and Distribution, by Region, 2017 and 2025
Figure 02: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, 2015–2025
Figure 03: Global Monocyte Activation Tests Market Value Share, by Product (2016)
Figure 04: Global Monocyte Activation Tests Market Value Share, by Source (2016)
Figure 05: Global Monocyte Activation Tests Market Value Share, by Application (2016)
Figure 06: Global Monocyte Activation Tests Market Value Share, by End-user (2016)
Figure 07: Global Monocyte Activation Tests Market Value Share, by Product, 2017 and 2025
Figure 08: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Monocyte Activation Tests Kits, 2015–2025
Figure 09: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Reagents, 2015–2025
Figure 10: Global Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 11: Global Monocyte Activation Tests Market Value Share, by Source, 2017 and 2025
Figure 12: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Blood-based, 2015–2025
Figure 13: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by PBMC-based, 2015–2025
Figure 14: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Cell Line-based, 2015–2025
Figure 15: Global Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 16: Global Monocyte Activation Tests Market Value Share, by Application, 2017 and 2025
Figure 17: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Lipid Parenteral, 2015–2025
Figure 18: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Dialysis Liquids, 2015–2025
Figure 19: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Toxic/immune-modulatory Drugs, 2015–2025
Figure 20: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Blood Products, 2015–2025
Figure 21: Global Monocyte Activation Tests Market Revenue (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, by Medical Devices, 2015–2025
Figure 22: Global Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 23: Global Monocyte Activation Tests Market Value Share, by End-user, 2017 and 2025
Figure 24: Global Monocyte Activation Tests Market Revenue (US$ Thousand) and Y-o-Y Growth (%) Forecast, by Pharmaceuticals Industry, 2015–2025
Figure 25: Global Monocyte Activation Tests Market Revenue (US$ Thousand) and Y-o-Y Growth (%) Forecast, by Biotechnology Industry, 2015–2025
Figure 26: Global Monocyte Activation Tests Market Revenue (US$ Thousand) and Y-o-Y Growth (%) Forecast, by Medical Devices Industry, 2015–2025
Figure 27: Global Monocyte Activation Tests Market Revenue (US$ Thousand) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 28: Global Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 29: Global Monocyte Activation Tests Market Value Share, by Region, 2017 and 2025
Figure 30: Global Monocyte Activation Tests Market Attractiveness, by Region, 2017–2025
Figure 31: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 32: North America Monocyte Activation Tests Market Value Share, by Country, 2017 and 2025
Figure 33: North America Monocyte Activation Tests Market Attractiveness, by Country, 2017–2025
Figure 34: North America Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 35: North America Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 36: North America Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 37: North America Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 38: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 39: Europe Monocyte Activation Tests Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 40: Europe Monocyte Activation Tests Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 41: Europe Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 42: Europe Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 43: Europe Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 44: Europe Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 45: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 46: Asia Pacific Monocyte Activation Tests Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 47: Asia Pacific Monocyte Activation Tests Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 48: Asia Pacific Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 49: Asia Pacific Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 50: Asia Pacific Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 51: Asia Pacific Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 52: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 53: Latin America Monocyte Activation Tests Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 54: Latin America Monocyte Activation Tests Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 55: Latin America Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 56: Latin America Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 57: Latin America Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 58: Latin America Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 59: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 60: Middle East & Africa Monocyte Activation Tests Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 61: Middle East & Africa Monocyte Activation Tests Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 62: Middle East & Africa Monocyte Activation Tests Market Attractiveness, by Product, 2017–2025
Figure 63: Middle East & Africa Monocyte Activation Tests Market Attractiveness, by Source, 2017–2025
Figure 64: Middle East & Africa Monocyte Activation Tests Market Attractiveness, by Application, 2017–2025
Figure 65: Middle East & Africa Monocyte Activation Tests Market Attractiveness, by End-user, 2017–2025
Figure 66: Merck KGaA Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 67: Merck KGaA Research & Development Expenses (US$ Mn), 2014–2016
Figure 68: Merck KGaA Breakdown of Net Sales, by Business Segment, 2016
Figure 69: Merck KGaA Breakdown of Net Sales, by Region, 2016
Figure 70: Thermo Fisher Scientific, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 71: Thermo Fisher Scientific, Inc. Research & Development Expenses (US$ Mn), 2014–2016
Figure 72: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Business Segment, 2016
Figure 73: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Region, 2016
Figure 74: Charles River Laboratories International, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 75: Charles River Laboratories International, Inc. Operating Expenses (US$ Mn), 2014–2016
Figure 76: Charles River Laboratories International, Inc. Breakdown of Net Sales, by Business Segment, 2016
Figure 77: Charles River Laboratories International, Inc. Breakdown of Net Sales, by Geography, 2016
Figure 78: Sanquin Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 79: Sanquin Reagents Segment Revenue (US$ Mn), 2014–2016
Figure 80: Sanquin Breakdown of Net Sales, by Business Segment, 2016
Figure 81: Sanquin Breakdown of Net Sales, by Geography, 2016
Figure 82: Becton, Dickinson and Company Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 83: Becton, Dickinson and Company Research and Development Expenses (US$ Mn), 2015–2017
Figure 84: Becton, Dickinson and Company Breakdown of Net Sales, by Business Segment, 2017
Figure 85: Becton, Dickinson and Company Breakdown of Net Sales, by Geography, 2017
Figure 86: Solvias AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 87: Solvias AG Breakdown of Net Sales, by Geography, 2017
Figure 88: Lonza Group Ltd Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 89: Lonza Group Ltd Operating Expenses (US$ Mn), 2015–2017
Figure 90: Lonza Group Ltd Breakdown of Net Sales, by Business Segment, 2017
Figure 91: Lonza Group Ltd Breakdown of Net Sales, by Geography, 2015

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Monocyte Activation Test Market